BDTX logo

Black Diamond Therapeutics, Inc. (BDTX)

Profile

Full Name

Black Diamond Therapeutics, Inc.

Ticker

NASDAQ: BDTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 31, 2020

Indexes

Not included

Website

https://www.blackdiamondtherapeutics.com

Employees

24

Key Details

Price

$2.59(-24.92%)

Market Cap

$147.57M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$1.27(32.49% YoY)

PE Ratio

7.14

Next earnings date

Mar 5, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.59
    BDTX price is $2.59

    30-Day Relative Volume

    8.74
    BDTX 30-day relative volume is 8.74

    Price Performance

    Price 1-Day Change

    -24.92%
    BDTX price is down -24.92% today

    Price YTD Change

    +21.03%
    BDTX price is up +21.03% since January 1st

    Price 1-Year Change

    +4.86%
    BDTX price is up +4.86% year-on-year

    Price 3-Year Change

    +31.48%
    BDTX price is up +31.48% over the past 3 years

    Price Range

    Price All-Time High

    $46.25
    BDTX price is currently -94.40% below its historical high of $46.25

    Price 3-Year Low

    $1.20
    BDTX price is currently +116.74% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $147.57M
    BDTX market cap is $147.57 million

    Market Cap 3-Year Change

    +105.99%
    BDTX market cap is up +105.99% over the past 3 years

    Market Cap All-Time High

    $1.61B
    BDTX market cap is currently -90.83% below its historical high of $1.61 billion

    Market Cap Sector Percentile

    45.82%
    BDTX market cap is higher than 45.82% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.69%
    BDTX shares outstanding is up +0.69% year-on-year

    Shares Outstanding 3-Year Change

    +56.67%
    BDTX shares outstanding is up +56.67% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.54
    BDTX beta is 1.54

    200-day SMA

    $2.68
    BDTX price is currently -3.46% below its 200-day simple moving average

    50-day SMA

    $3.89
    BDTX price is currently -33.45% below its 50-day simple moving average

    14-Day RSI

    37.47
    BDTX 14-day relative strength index is 37.47

    Volume

    8.74
    BDTX 30-day relative volume is 8.74

    ATR

    $0.26
    BDTX average true range is $0.26

    10-day Historical Volatility

    44.44%
    BDTX 10-day historical volatility is 44.44%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    BDTX annual revenue is $0.00

    Revenue Analysts Estimate

    $70.00M
    BDTX annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    0%
    BDTX annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.31%
    BDTX annual revenue is higher than 28.31% of companies in Healthcare sector

    EPS

    EPS

    -$1.27
    BDTX annual earnings per share is -$1.27

    EPS Analysts Estimate

    $0.44
    BDTX annual earnings per share is currently -386.86% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +32.49%
    BDTX annual earnings per share is up +32.49% year-on-year

    EPS Sector Percentile

    50.29%
    BDTX annual earnings per share is higher than 50.29% of companies in Healthcare sector

    Profit

    Gross Profit

    -$343.00K
    BDTX annual gross profit is -$343.00 thousand

    Gross Margin

    -
    BDTX annual gross profit margin value is unknown

    Operating Profit

    -$78.78M
    BDTX annual operating income is -$78.78 million

    Operating Margin

    -
    BDTX annual operating profit margin value is unknown

    Net Income

    -$69.68M
    BDTX annual net profit is -$69.68 million

    Net Margin

    -
    BDTX annual net profit margin value is unknown

    Expenses

    Total Expenses

    $78.78M
    BDTX annual total expenses is $78.78 million

    Operating Expenses

    $78.78M
    BDTX annual total operating expenses is $78.78 million

    Cost Of Goods Sold

    $343.00K
    BDTX annual cost of goods sold is $343.00 thousand

    Selling, General & Administrative Expenses

    $27.47M
    BDTX annual SG&A is $27.47 million

    Depreciation & Amortization

    $343.00K
    BDTX annual D&A is $343.00 thousand

    Interest Expense

    $0.00
    BDTX annual interest expense is $0.00

    Income Tax

    $0.00
    BDTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$78.78M
    BDTX annual earnings before interest & taxes is -$78.78 million

    EBITDA

    -$78.44M
    BDTX annual EBITDA is -$78.44 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $122.64M
    BDTX annual total assets is $122.64 million

    Non Current Assets

    $21.46M
    BDTX annual long term assets is $21.46 million

    Current Assets

    $101.18M
    BDTX annual total current assets is $101.18 million

    Cash and Cash Equivalents

    $36.44M
    BDTX annual cash & cash equivalents is $36.44 million

    Accounts Receivable

    -
    BDTX annual accounts receivable value is unknown

    Inventory

    $0.00
    BDTX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $39.35M
    BDTX annual total liabilities is $39.35 million

    Long Term Liabilities

    $18.78M
    BDTX annual total long term liabilities is $18.78 million

    Current Liabilities

    $20.57M
    BDTX annual current liabilities is $20.57 million

    Accounts Payable

    $4.01M
    BDTX annual accounts payable is $4.01 million

    Debt

    Total Debt

    $22.19M
    BDTX annual total debt is $22.19 million

    Total Debt 1-Year Change

    -12.3%
    BDTX annual total debt is down -12.3% year-on-year

    Long Term Debt

    $18.78M
    BDTX annual long term debt is $18.78 million

    Short Term Debt

    $3.40M
    BDTX annual short term debt is $3.40 million

    Equity & Capital

    Shareholders Equity

    $83.28M
    BDTX annual stockholders equity is $83.28 million

    Book Value

    $83.28M
    BDTX annual book value is $83.28 million

    Retained Earnings

    -$487.11M
    BDTX annual retained earnings is -$487.11 million

    Working Capital

    $80.60M
    BDTX annual working capital is $80.60 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$62.30M
    BDTX annual cash from operations is -$62.30 million

    Cash From Operations 1-Year Change

    +6.62%
    BDTX annual cash from operations is up +6.62% year-on-year

    Cash From Investing

    $16.97M
    BDTX annual cash from investing is $16.97 million

    Cash From Investing 1-Year Change

    +3.81%
    BDTX annual cash from investing is up +3.81% year-on-year

    Cash From Financing

    $25.55M
    BDTX annual cash from financing is $25.55 million

    Cash From Financing 1-Year Change

    -64.48%
    BDTX annual cash from financing is down -64.48% year-on-year

    CAPEX

    CAPEX

    $0.00
    BDTX annual capital expenditures is $0.00

    CAPEX 1-Year Change

    -100%
    BDTX annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$62.30M
    BDTX annual free cash flow is -$62.30 million

    Free Cash Flow 1-Year Change

    +6.66%
    BDTX annual free cash flow is up +6.66% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    BDTX annual gross profit margin value is unknown

    Operating Margin

    -
    BDTX annual operating profit margin value is unknown

    Net Margin

    -
    BDTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -49.56%
    BDTX annual return on assets is -49.56%

    ROE

    -69.67%
    BDTX annual return on equity is -69.67%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    7.14
    BDTX price to earnings ratio is 7.14

    PE Ratio Sector Percentile

    10.78%
    BDTX price to earnings ratio is higher than 10.78% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    1.17
    BDTX price to book ratio is 1.17

    PB Ratio Sector Percentile

    39.18%
    BDTX price to book ratio is higher than 39.18% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    2.11
    BDTX price to sales ratio is 2.11

    PS Ratio Sector Percentile

    36.47%
    BDTX price to sales ratio is higher than 36.47% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $31.74M
    BDTX enterprise value is $31.74 million

    Enterprise Value Sector Percentile

    32.05%
    BDTX enterprise value is higher than 32.05% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    2.60
    BDTX EV/EBITDA is 2.60

    EV/EBITDA Sector Percentile

    73.73%
    BDTX EV/EBITDA is higher than 73.73% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    4.92
    BDTX annual current ratio is 4.92

    Quick Ratio

    4.92
    BDTX annual quick ratio is 4.92

    Leverage

    Debt To Equity

    0.27
    BDTX annual debt to equity ratio is 0.27

    Interest Coverage Ratio

    -
    BDTX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    BDTX piotroski f-score value is unknown

    Altman Z-Score

    -4.64
    BDTX altman z-score is -4.64

    Analyst ratings

    Recent major analysts updates

    Sep 4, 25 Guggenheim
    Buy
    Aug 11, 25 HC Wainwright & Co.
    Buy
    Mar 18, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 Stifel
    Buy
    Nov 6, 24 HC Wainwright & Co.
    Buy
    Oct 9, 24 HC Wainwright & Co.
    Buy
    Oct 8, 24 Wedbush
    Outperform
    Sep 24, 24 HC Wainwright & Co.
    Buy
    Sep 23, 24 Piper Sandler
    Overweight
    Sep 18, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with BDTX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Black Diamond Therapeutics, Inc.?
    • Does Black Diamond Therapeutics, Inc. pay dividends?
    • What sector is Black Diamond Therapeutics, Inc. in?
    • What industry is Black Diamond Therapeutics, Inc. in?
    • What country is Black Diamond Therapeutics, Inc. based in?
    • When did Black Diamond Therapeutics, Inc. go public?
    • Is Black Diamond Therapeutics, Inc. in the S&P 500?
    • Is Black Diamond Therapeutics, Inc. in the NASDAQ 100?
    • Is Black Diamond Therapeutics, Inc. in the Dow Jones?
    • When was Black Diamond Therapeutics, Inc.'s last earnings report?
    • When does Black Diamond Therapeutics, Inc. report earnings?

    What is the ticker symbol for Black Diamond Therapeutics, Inc.?

    The ticker symbol for Black Diamond Therapeutics, Inc. is NASDAQ:BDTX

    Does Black Diamond Therapeutics, Inc. pay dividends?

    No, Black Diamond Therapeutics, Inc. does not pay dividends

    What sector is Black Diamond Therapeutics, Inc. in?

    Black Diamond Therapeutics, Inc. is in the Healthcare sector

    What industry is Black Diamond Therapeutics, Inc. in?

    Black Diamond Therapeutics, Inc. is in the Biotechnology industry

    What country is Black Diamond Therapeutics, Inc. based in?

    Black Diamond Therapeutics, Inc. is headquartered in United States

    When did Black Diamond Therapeutics, Inc. go public?

    Black Diamond Therapeutics, Inc.'s initial public offering (IPO) was on January 31, 2020

    Is Black Diamond Therapeutics, Inc. in the S&P 500?

    No, Black Diamond Therapeutics, Inc. is not included in the S&P 500 index

    Is Black Diamond Therapeutics, Inc. in the NASDAQ 100?

    No, Black Diamond Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Black Diamond Therapeutics, Inc. in the Dow Jones?

    No, Black Diamond Therapeutics, Inc. is not included in the Dow Jones index

    When was Black Diamond Therapeutics, Inc.'s last earnings report?

    Black Diamond Therapeutics, Inc.'s most recent earnings report was on November 6, 2025

    When does Black Diamond Therapeutics, Inc. report earnings?

    The next expected earnings date for Black Diamond Therapeutics, Inc. is March 5, 2026
    On this page